tracon pharmaceuticals inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report tracon pharmaceuticals inc  product pipeline review   published by global markets direct product code  published august   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license tracon pharmaceuticals inc  product pipeline review   published august   content info  pages description summary global markets directs tracon pharmaceuticals inc  product pipeline review   provides an overview of the tracon pharmaceuticals incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of tracon pharmaceuticals incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of tracon pharmaceuticals inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of tracon pharmaceuticals incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the tracon pharmaceuticals incs pipeline products reasons to buy evaluate tracon pharmaceuticals incs strategic position with total access to detailed information on its product pipeline assess the growth potential of tracon pharmaceuticals inc in its therapy areas of focus identify new drug targets and therapeutic classes in the tracon pharmaceuticals incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of tracon pharmaceuticals inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of tracon pharmaceuticals inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of tracon pharmaceuticals inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures tracon pharmaceuticals inc snapshot tracon pharmaceuticals inc overview key information key facts tracon pharmaceuticals inc  research and development overview key therapeutic areas tracon pharmaceuticals inc  pipeline review pipeline products by stage of development pipeline products  monotherapy tracon pharmaceuticals inc  pipeline products glance tracon pharmaceuticals inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities tracon pharmaceuticals inc  early stage pipeline products indcta filed productscombination treatment modalities preclinical productscombination treatment modalities tracon pharmaceuticals inc  drug profiles trc product description mechanism of action rd progress trc product description mechanism of action rd progress trc product description mechanism of action rd progress tracon pharmaceuticals inc  pipeline analysis tracon pharmaceuticals inc  pipeline products by target tracon pharmaceuticals inc  pipeline products by route of administration tracon pharmaceuticals inc  pipeline products by molecule type tracon pharmaceuticals inc  pipeline products by mechanism of action tracon pharmaceuticals inc  recent pipeline updates tracon pharmaceuticals inc  dormant projects tracon pharmaceuticals inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables tracon pharmaceuticals inc key information tracon pharmaceuticals inc key facts tracon pharmaceuticals inc  pipeline by indication  tracon pharmaceuticals inc  pipeline by stage of development  tracon pharmaceuticals inc  monotherapy products in pipeline  tracon pharmaceuticals inc  phase ii  tracon pharmaceuticals inc  phase i  tracon pharmaceuticals inc  indcta filed  tracon pharmaceuticals inc  preclinical  tracon pharmaceuticals inc  pipeline by target  tracon pharmaceuticals inc  pipeline by route of administration  tracon pharmaceuticals inc  pipeline by molecule type  tracon pharmaceuticals inc  pipeline products by mechanism of action  tracon pharmaceuticals inc  recent pipeline updates  tracon pharmaceuticals inc  dormant developmental projects list of figures tracon pharmaceuticals inc  pipeline by top  indication  tracon pharmaceuticals inc  pipeline by stage of development  tracon pharmaceuticals inc  monotherapy products in pipeline  tracon pharmaceuticals inc  pipeline by top  target  tracon pharmaceuticals inc  pipeline by top  route of administration  tracon pharmaceuticals inc  pipeline by top  molecule type  tracon pharmaceuticals inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved tracon pharmaceuticals inc private company information  bloomberg july    pm et biotechnology company overview of tracon pharmaceuticals inc snapshot people company overview tracon pharmaceuticals inc a clinical stage biopharmaceutical company focuses on the development and commercialization of therapeutics for cancer wet agerelated macular degeneration amd and fibrotic diseases its lead product candidate is trc an endoglin antibody which is in phase iii clinical trials for angiosarcoma randomized phase ii clinical trials for renal cell carcinoma phase ii clinical trials for soft tissue sarcoma phase ii clinical trials for gestational trophoblastic neoplasia phase iii clinical trials for hepatocellular carcinoma phase i clinical trial for lung cancer phase iii clinical trials for breast cancer and phase iii clinical trials for wet amd t tracon pharmaceuticals inc a clinical stage biopharmaceutical company focuses on the development and commercialization of therapeutics for cancer wet agerelated macular degeneration amd and fibrotic diseases its lead product candidate is trc an endoglin antibody which is in phase iii clinical trials for angiosarcoma randomized phase ii clinical trials for renal cell carcinoma phase ii clinical trials for soft tissue sarcoma phase ii clinical trials for gestational trophoblastic neoplasia phase iii clinical trials for hepatocellular carcinoma phase i clinical trial for lung cancer phase iii clinical trials for breast cancer and phase iii clinical trials for wet amd the company’s other product candidates comprise trc a small molecule that is in phase ii clinical trials for mesothelioma phase ii clinical trials for glioblastoma phase i clinical trial for solid tumors and lymphomas as well as phase i clinical trial for lung cancer and trc a small molecule high affinity competitive inhibitor of wild type androgen receptor ar and multiple ar mutant receptors that is in phase iii clinical trials for the treatment prostate cancer its preclinical development products include trc an endoglin antibody for the treatment of fibrotic diseases and trc an orally bioavailable inhibitor of nfkb inducing kinase for the treatment of patients with hematologic malignancies including myeloma the company has a strategic licensing collaboration with janssen pharmaceutica nv to develop trc and trc and a license agreement with santen pharmaceutical co ltd to develop manufacture and commercialize de the ophthalmic formulation of trc for ophthalmology indications the company was formerly known as lexington pharmaceuticals inc and changed its name to tracon pharmaceuticals inc in march  tracon pharmaceuticals inc was founded in  and is headquartered in san diego california detailed description  university center lanesuite san diego ca united statesfounded in  employees phone  fax  wwwtraconpharmacom key executives for tracon pharmaceuticals inc dr charles p theuer md phd chief executive officer president and director age  total annual compensation k ms patricia l bitar cpa chief financial officer treasurer and assistant secretary age  total annual compensation k mr h casey logan mba chief business officer age  total annual compensation k compensation as of fiscal year  tracon pharmaceuticals inc key developments santen pharmaceutical co ltd and tracon pharmaceuticals inc announce initiation of a phase a clinical study of de in patients with wet agerelated macular degeneration jul   santen pharmaceutical co ltd and tracon pharmaceuticals inc announced that santen has initiated a phase a clinical study of de in patients with wet agerelated macular degeneration amd the phase a study is a randomized controlled trial assessing the efficacy and safety of intravitreal injections of de in combination with lucentis® ranibizumab compared to lucentis monotherapy in patients with wet amd de is the ophthalmic formulation of tracon’s proprietary antiendoglin antibody trc the initiation of the phase a study triggers a usd  million milestone payment from santen to tracon tracon pharmaceuticals presents positive clinical data from trc and trc studies jun   tracon pharmaceuticals reported positive clinical results from multiple studies with trc and trc at the american society of clinical oncology asco  annual meeting in chicago il observed correlation of biomarker status with activity of trc with votrient® pazopanib in advanced soft tissue sarcoma in this phase b trial patients who had greater than a  reduction in tumor volume following treatment with trc and votrient were significantly more likely to have lower baseline levels of soluble intracellular adhesion molecule icam p and thrombospondin p these biomarkers will be assessed separately as part of the completed  patient phase  trial of trc and votrient in soft tissue sarcoma and in the ongoing randomized phase  tappas trial of trc and votrient in patients with angiosarcoma observed correlation of biomarker status with activity of trc with inlyta® axitinib in advanced renal cell carcinoma in this phase b trial patients with a partial response by recist  following treatment with trc and inlyta were more likely to have lower levels of soluble osteopontin p and higher levels of soluble transforming growth factorß receptor iii p these biomarkers will also be assessed as part of the ongoing randomized phase  traxar study of trc and inlyta in patients with renal cell carcinoma data from a phase  trial of trc with temodar® temozolomide in patients with solid tumors the national cancer institute nci reported data from a trial of trc in combination with temodar in patients with refractory solid tumors based on partial responses in patients with kraspositive colorectal cancer ovarian cancer and nonsmall cell lung cancer the nci decided to enroll expansion cohorts in each of these tumor types at the recommended phase  oral dose of trc of  mgm the authors concluded that the combination of temodar and trc is active and dna damage response markers rad hax andor pnbs were induced in  of  paired colon biopsies indicating dna damage following treatment tracon pharmaceuticals inc presents at jefferies  global healthcare conference jun  pm may   tracon pharmaceuticals inc presents at jefferies  global healthcare conference jun  pm venue grand hyatt  e nd st new york new york united states speakers charles p theuer chief executive officer president and director similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target private placement march    private placement september    request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact tracon pharmaceuticals inc please visit wwwtraconpharmacom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  tcon stock price  tracon pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states tcon overview compare quotes stock screener earnings calendar sectors nasdaq tcon us nasdaq join td ameritrade find a broker tracon pharmaceuticals inc watchlist createtconalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available no headlines available recent news other news press releases tracon nabs m milestone from santen on initiation of midstage study of ophthalmic formulation of trc shares up  tracon nabs m milestone from santen on initiation of midstage study of ophthalmic formulation of trc shares up  jul   at  am et on seeking alpha tracon pharma perks up ahead of asco presentations shares ahead  tracon pharma perks up ahead of asco presentations shares ahead  may   at  pm et on seeking alpha tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript may   at  pm et on seeking alpha q tracon pharmaceuticals inc q tracon pharmaceuticals inc may   at  pm et on edgar online  edg  q k k tracon pharmaceuticals inc mar   at  am et on edgar online  edg  q k tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript feb   at  pm et on seeking alpha tracon pharmaceuticals an underdog can rise up feb   at  am et on seeking alpha tracons latestage study underway assessing lead product candidate trc in angiosarcoma feb   at  am et on seeking alpha biotech forum daily digest buyout rumors on the rise aratana therapeutics decline is overblown feb   at  am et on seeking alpha tracon pharmas lead product candidate flunks midstage study in brain cancer feb   at  am et on seeking alpha tracon pharma clarifies development path for lead product candidate shares ahead  jan   at  am et on seeking alpha biggest movers in manufacturing stocks now – imgn ons spcb bioa jan   at  am et on investorplacecom hottest manufacturing stocks now – dprx tcon catb zyne dec   at  am et on investorplacecom hottest manufacturing stocks now – mrus cala invn mntx dec   at  am et on investorplacecom hottest manufacturing stocks now – glf adhd fbio cris dec   at  pm et on investorplacecom hottest manufacturing stocks now – aqxp cris ftk ppsi dec   at  pm et on investorplacecom biggest movers in manufacturing stocks now – bosc tcon vtvt grfs dec   at  am et on investorplacecom insiders roundup alphabet scripps phillips  dec   at  pm et on gurufocuscom insiderinsightscom daily round up  bsm enzn tcon nov   at  am et on seeking alpha biggest movers in manufacturing stocks now – de elon cnhi hchc nov   at  am et on investorplacecom santen and tracon announce initiation of a phase a study of de for the treatment of wet agerelated macular degeneration santen and tracon announce initiation of a phase a study of de for the treatment of wet agerelated macular degeneration jul   at  pm et on globenewswire tracon pharmaceuticals presents positive clinical data from trc and trc studies at american society of clinical oncology asco  annual meeting tracon pharmaceuticals presents positive clinical data from trc and trc studies at american society of clinical oncology asco  annual meeting jun   at  pm et on globenewswire tracon pharmaceuticals to present at the jefferies  healthcare conference tracon pharmaceuticals to present at the jefferies  healthcare conference may   at  pm et on globenewswire tracon announces clinical data presentations at upcoming asco annual meeting tracon announces clinical data presentations at upcoming asco annual meeting may   at  pm et on globenewswire tracon doses first patient in phase  study of trc in patients with prostate cancer tracon doses first patient in phase  study of trc in patients with prostate cancer may   at  am et on globenewswire tracon pharmaceuticals announces publication in blood of preclinical data indicating activity of trc in acute myeloid leukemia and bcell acute lymphoblastic leukemia tracon pharmaceuticals announces publication in blood of preclinical data indicating activity of trc in acute myeloid leukemia and bcell acute lymphoblastic leukemia may   at  pm et on globenewswire tracon pharmaceuticals reports first quarter financial results and provides corporate update tracon pharmaceuticals reports first quarter financial results and provides corporate update may   at  pm et on globenewswire investor network tracon pharmaceuticals inc to host earnings call investor network tracon pharmaceuticals inc to host earnings call may   at  am et on accesswire tracon to report first quarter company highlights and financial results on may   tracon to report first quarter company highlights and financial results on may   may   at  pm et on globenewswire tracon awarded most innovative trial design for phase  tappas clinical trial of trc in angiosarcoma at  clinical and research excellence awards apr   at  pm et on globenewswire tracon pharmaceuticals to present at the th annual needham healthcare conference mar   at  pm et on globenewswire tracon pharmaceuticals announces trc data presentation at upcoming aacr annual meeting mar   at  pm et on globenewswire tracon pharmaceuticals announces  million common stock purchase agreement with aspire capital fund llc mar   at  pm et on globenewswire tracon pharmaceuticals to present at the th annual roth conference mar   at  pm et on globenewswire tracon pharmaceuticals reports fourth quarter and yearend  financial results and provides corporate update feb   at  pm et on globenewswire tracon to report fourth quarter and full year  company highlights and financial results on february   feb   at  pm et on globenewswire tracon pharmaceuticals announces first patient dosed in phase  tappas trial of trc in angiosarcoma feb   at  am et on globenewswire tracon pharmaceuticals announces topline results from ncisponsored phase  trial of trc in recurrent glioblastoma feb   at  pm et on globenewswire tracon pharmaceuticals receives special protocol assessment spa agreement from fda for phase  clinical trial of trc in angiosarcoma jan   at  am et on globenewswire tracon pharmaceuticals announces closing of public offering and full exercise of option to purchase additional shares nov   at  pm et on globenewswire tracon pharmaceuticals inc tracon pharmaceuticals inc is a clinical stage biopharmaceutical company it focuses on the development and commercialization of novel targeted therapeutics for cancer agerelated macular degeneration and fibrotic diseases the company products include trc is an antiendoglin antibody that is being developed for the treatment of multiple solid tumor types trc an antiendoglin antibody that is in preclinical development for the treatment of fibrotic diseases and trc a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma tracon pharmaceuticals was founded in october  and is headquartered in san diego ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings tracons promising tumor treatments make the stock a buy aug   at  am et on benzingacom the smallcap biotech that could double after new data is released midseptember sep   at  pm et on benzingacom benzingas top initiations jul   at  am et on benzingacom competitors name chg  market cap biocryst pharmaceuticals inc  m aveo pharmaceuticals inc  m atara biotherapeutics inc  m asterias biotherapeutics inc  m competitor data provided by partner content trending tickers powered by dvax  mo  ssti  s  blcm  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  tracon pharmaceuticals targeted therapeutics for cancer and ophthalmology our goal is to be a leader in the development of targeted therapies for patients with cancer and other diseases of high unmet need in the news tracon pharmaceuticals targeted therapeutics for cancer and ophthalmology our goal is to be a leader in the development of targeted therapies for patients with cancer and other diseases of high unmet need in the news tracon pharmaceuticals targeted therapeutics for cancer and ophthalmology our goal is to be a leader in the development of targeted therapies for patients with cancer and other diseases of high unmet need in the news tcon stock price  tracon pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states tcon overview compare quotes stock screener earnings calendar sectors nasdaq tcon us nasdaq join td ameritrade find a broker tracon pharmaceuticals inc watchlist createtconalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available no headlines available recent news other news press releases tracon nabs m milestone from santen on initiation of midstage study of ophthalmic formulation of trc shares up  tracon nabs m milestone from santen on initiation of midstage study of ophthalmic formulation of trc shares up  jul   at  am et on seeking alpha tracon pharma perks up ahead of asco presentations shares ahead  tracon pharma perks up ahead of asco presentations shares ahead  may   at  pm et on seeking alpha tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript may   at  pm et on seeking alpha q tracon pharmaceuticals inc q tracon pharmaceuticals inc may   at  pm et on edgar online  edg  q k k tracon pharmaceuticals inc mar   at  am et on edgar online  edg  q k tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript feb   at  pm et on seeking alpha tracon pharmaceuticals an underdog can rise up feb   at  am et on seeking alpha tracons latestage study underway assessing lead product candidate trc in angiosarcoma feb   at  am et on seeking alpha biotech forum daily digest buyout rumors on the rise aratana therapeutics decline is overblown feb   at  am et on seeking alpha tracon pharmas lead product candidate flunks midstage study in brain cancer feb   at  am et on seeking alpha tracon pharma clarifies development path for lead product candidate shares ahead  jan   at  am et on seeking alpha biggest movers in manufacturing stocks now – imgn ons spcb bioa jan   at  am et on investorplacecom hottest manufacturing stocks now – dprx tcon catb zyne dec   at  am et on investorplacecom hottest manufacturing stocks now – mrus cala invn mntx dec   at  am et on investorplacecom hottest manufacturing stocks now – glf adhd fbio cris dec   at  pm et on investorplacecom hottest manufacturing stocks now – aqxp cris ftk ppsi dec   at  pm et on investorplacecom biggest movers in manufacturing stocks now – bosc tcon vtvt grfs dec   at  am et on investorplacecom insiders roundup alphabet scripps phillips  dec   at  pm et on gurufocuscom insiderinsightscom daily round up  bsm enzn tcon nov   at  am et on seeking alpha biggest movers in manufacturing stocks now – de elon cnhi hchc nov   at  am et on investorplacecom santen and tracon announce initiation of a phase a study of de for the treatment of wet agerelated macular degeneration santen and tracon announce initiation of a phase a study of de for the treatment of wet agerelated macular degeneration jul   at  pm et on globenewswire tracon pharmaceuticals presents positive clinical data from trc and trc studies at american society of clinical oncology asco  annual meeting tracon pharmaceuticals presents positive clinical data from trc and trc studies at american society of clinical oncology asco  annual meeting jun   at  pm et on globenewswire tracon pharmaceuticals to present at the jefferies  healthcare conference tracon pharmaceuticals to present at the jefferies  healthcare conference may   at  pm et on globenewswire tracon announces clinical data presentations at upcoming asco annual meeting tracon announces clinical data presentations at upcoming asco annual meeting may   at  pm et on globenewswire tracon doses first patient in phase  study of trc in patients with prostate cancer tracon doses first patient in phase  study of trc in patients with prostate cancer may   at  am et on globenewswire tracon pharmaceuticals announces publication in blood of preclinical data indicating activity of trc in acute myeloid leukemia and bcell acute lymphoblastic leukemia tracon pharmaceuticals announces publication in blood of preclinical data indicating activity of trc in acute myeloid leukemia and bcell acute lymphoblastic leukemia may   at  pm et on globenewswire tracon pharmaceuticals reports first quarter financial results and provides corporate update tracon pharmaceuticals reports first quarter financial results and provides corporate update may   at  pm et on globenewswire investor network tracon pharmaceuticals inc to host earnings call investor network tracon pharmaceuticals inc to host earnings call may   at  am et on accesswire tracon to report first quarter company highlights and financial results on may   tracon to report first quarter company highlights and financial results on may   may   at  pm et on globenewswire tracon awarded most innovative trial design for phase  tappas clinical trial of trc in angiosarcoma at  clinical and research excellence awards apr   at  pm et on globenewswire tracon pharmaceuticals to present at the th annual needham healthcare conference mar   at  pm et on globenewswire tracon pharmaceuticals announces trc data presentation at upcoming aacr annual meeting mar   at  pm et on globenewswire tracon pharmaceuticals announces  million common stock purchase agreement with aspire capital fund llc mar   at  pm et on globenewswire tracon pharmaceuticals to present at the th annual roth conference mar   at  pm et on globenewswire tracon pharmaceuticals reports fourth quarter and yearend  financial results and provides corporate update feb   at  pm et on globenewswire tracon to report fourth quarter and full year  company highlights and financial results on february   feb   at  pm et on globenewswire tracon pharmaceuticals announces first patient dosed in phase  tappas trial of trc in angiosarcoma feb   at  am et on globenewswire tracon pharmaceuticals announces topline results from ncisponsored phase  trial of trc in recurrent glioblastoma feb   at  pm et on globenewswire tracon pharmaceuticals receives special protocol assessment spa agreement from fda for phase  clinical trial of trc in angiosarcoma jan   at  am et on globenewswire tracon pharmaceuticals announces closing of public offering and full exercise of option to purchase additional shares nov   at  pm et on globenewswire tracon pharmaceuticals inc tracon pharmaceuticals inc is a clinical stage biopharmaceutical company it focuses on the development and commercialization of novel targeted therapeutics for cancer agerelated macular degeneration and fibrotic diseases the company products include trc is an antiendoglin antibody that is being developed for the treatment of multiple solid tumor types trc an antiendoglin antibody that is in preclinical development for the treatment of fibrotic diseases and trc a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma tracon pharmaceuticals was founded in october  and is headquartered in san diego ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings tracons promising tumor treatments make the stock a buy aug   at  am et on benzingacom the smallcap biotech that could double after new data is released midseptember sep   at  pm et on benzingacom benzingas top initiations jul   at  am et on benzingacom competitors name chg  market cap biocryst pharmaceuticals inc  m aveo pharmaceuticals inc  m atara biotherapeutics inc  m asterias biotherapeutics inc  m competitor data provided by partner content trending tickers powered by dvax  mo  ssti  s  blcm  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience tcon news  tracon pharmaceuticals inc company news  press releases  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close tracon pharmaceuticals inc nasdaq tcon go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus tracon pharmaceuticals inc market closed  quotes are delayed by  min jul    pm tcon quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   newslatestcompanyustcon marketwatch news on tcon no news currently available for tcon newsnonmarketwatchcompanyustcon other news on tcon tracon nabs m milestone from santen on initiation of midstage study of ophthalmic formulation of trc shares up   am july    seeking alpha tracon pharma perks up ahead of asco presentations shares ahead   pm may    seeking alpha tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript  pm may    seeking alpha q tracon pharmaceuticals inc  pm may    edgar online  edg  q k k tracon pharmaceuticals inc  am march    edgar online  edg  q k tracon pharmaceuticals tcon ceo charles theuer on q  results  earnings call transcript  am march    seeking alpha tracon pharmaceuticals an underdog can rise up  pm feb    seeking alpha tracons latestage study underway assessing lead product candidate trc in angiosarcoma  am feb    seeking alpha biotech forum daily digest buyout rumors on the rise aratana therapeutics decline is overblown  pm feb    seeking alpha tracon pharmas lead product candidate flunks midstage study in brain cancer  am feb    seeking alpha tracon pharma clarifies development path for lead product candidate shares ahead   am jan    seeking alpha biggest movers in manufacturing stocks now – imgn ons spcb bioa  pm jan    investorplacecom hottest manufacturing stocks now – dprx tcon catb zyne  am dec    investorplacecom hottest manufacturing stocks now – mrus cala invn mntx  am dec    investorplacecom hottest manufacturing stocks now – glf adhd fbio cris  pm dec    investorplacecom hottest manufacturing stocks now – aqxp cris ftk ppsi  pm dec    investorplacecom biggest movers in manufacturing stocks now – bosc tcon vtvt grfs  am dec    investorplacecom insiders roundup alphabet scripps phillips   pm dec    gurufocuscom insiderinsightscom daily round up  bsm enzn tcon  am nov    seeking alpha biggest movers in manufacturing stocks now – de elon cnhi hchc  am nov    investorplacecom loading more headlines newspressreleasecompanyustcon press releases on tcon santen and tracon announce initiation of a phase a study of de for the treatment of wet agerelated macular degeneration  pm july    globenewswire tracon pharmaceuticals presents positive clinical data from trc and trc studies at american society of clinical oncology asco  annual meeting  pm june    globenewswire tracon pharmaceuticals to present at the jefferies  healthcare conference  pm may    globenewswire tracon announces clinical data presentations at upcoming asco annual meeting  pm may    globenewswire tracon doses first patient in phase  study of trc in patients with prostate cancer  am may    globenewswire tracon pharmaceuticals announces publication in blood of preclinical data indicating activity of trc in acute myeloid leukemia and bcell acute lymphoblastic leukemia  pm may    globenewswire tracon pharmaceuticals reports first quarter financial results and provides corporate update  pm may    globenewswire investor network tracon pharmaceuticals inc to host earnings call  am may    accesswire tracon to report first quarter company highlights and financial results on may    pm may    globenewswire tracon awarded most innovative trial design for phase  tappas clinical trial of trc in angiosarcoma at  clinical and research excellence awards  pm april    globenewswire tracon pharmaceuticals to present at the th annual needham healthcare conference  pm march    globenewswire tracon pharmaceuticals announces trc data presentation at upcoming aacr annual meeting  pm march    globenewswire tracon pharmaceuticals announces  million common stock purchase agreement with aspire capital fund llc  pm march    globenewswire tracon pharmaceuticals to present at the th annual roth conference  pm march    globenewswire tracon pharmaceuticals reports fourth quarter and yearend  financial results and provides corporate update  pm feb    globenewswire tracon to report fourth quarter and full year  company highlights and financial results on february    pm feb    globenewswire tracon pharmaceuticals announces first patient dosed in phase  tappas trial of trc in angiosarcoma  am feb    globenewswire tracon pharmaceuticals announces topline results from ncisponsored phase  trial of trc in recurrent glioblastoma  pm feb    globenewswire tracon pharmaceuticals receives special protocol assessment spa agreement from fda for phase  clinical trial of trc in angiosarcoma  am jan    globenewswire tracon pharmaceuticals announces closing of public offering and full exercise of option to purchase additional shares  pm nov    globenewswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  tracon pharmaceuticals inc  product pipeline review   trends statistics segment and forecasts market size share analysis  market research store     gmt office hours  uscan toll free  us office no home categories become publisher news about us contact us select category consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media semiconductor chemical and materials metallurgical market research search home  life sciences  pharmaceuticals tracon pharmaceuticals inc  product pipeline review   published aug  format pdf  global markets direct  number of pages   code mrs   report details table of content inquiry for buying request sample tracon pharmaceuticals inc  product pipeline review   summary global markets direct’s ‘tracon pharmaceuticals inc  product pipeline review  ’ provides an overview of the tracon pharmaceuticals inc’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of tracon pharmaceuticals inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of tracon pharmaceuticals inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of tracon pharmaceuticals inc’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the tracon pharmaceuticals inc’s pipeline products reasons to buy  evaluate tracon pharmaceuticals inc’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of tracon pharmaceuticals inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the tracon pharmaceuticals inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of tracon pharmaceuticals inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of tracon pharmaceuticals inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of tracon pharmaceuticals inc and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  tracon pharmaceuticals inc snapshot  tracon pharmaceuticals inc overview  key information  key facts  tracon pharmaceuticals inc  research and development overview  key therapeutic areas  tracon pharmaceuticals inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  tracon pharmaceuticals inc  pipeline products glance  tracon pharmaceuticals inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  tracon pharmaceuticals inc  early stage pipeline products  indcta filed productscombination treatment modalities  preclinical productscombination treatment modalities  tracon pharmaceuticals inc  drug profiles  trc  product description  mechanism of action  rd progress  trc  product description  mechanism of action  rd progress  trc  product description  mechanism of action  rd progress  tracon pharmaceuticals inc  pipeline analysis  tracon pharmaceuticals inc  pipeline products by target  tracon pharmaceuticals inc  pipeline products by route of administration  tracon pharmaceuticals inc  pipeline products by molecule type  tracon pharmaceuticals inc  pipeline products by mechanism of action  tracon pharmaceuticals inc  recent pipeline updates  tracon pharmaceuticals inc  dormant projects  tracon pharmaceuticals inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables tracon pharmaceuticals inc key information  tracon pharmaceuticals inc key facts  tracon pharmaceuticals inc  pipeline by indication   tracon pharmaceuticals inc  pipeline by stage of development   tracon pharmaceuticals inc  monotherapy products in pipeline   tracon pharmaceuticals inc  phase ii   tracon pharmaceuticals inc  phase i   tracon pharmaceuticals inc  indcta filed   tracon pharmaceuticals inc  preclinical   tracon pharmaceuticals inc  pipeline by target   tracon pharmaceuticals inc  pipeline by route of administration   tracon pharmaceuticals inc  pipeline by molecule type   tracon pharmaceuticals inc  pipeline products by mechanism of action   tracon pharmaceuticals inc  recent pipeline updates   tracon pharmaceuticals inc  dormant developmental projects  list of figures tracon pharmaceuticals inc  pipeline by top  indication   tracon pharmaceuticals inc  pipeline by stage of development   tracon pharmaceuticals inc  monotherapy products in pipeline   tracon pharmaceuticals inc  pipeline by top  target   tracon pharmaceuticals inc  pipeline by top  route of administration   tracon pharmaceuticals inc  pipeline by top  molecule type   tracon pharmaceuticals inc  pipeline products by top  mechanism of action   inquiry for buying please fill your details below to inquire about this report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit request sample please fill your details below to receive sample report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit related reports global and europe bcg vaccine market  analysis and outlook to  jul  eu research  pages    code  mrs   this report presents a comprehensive overview of the bcg vaccine market in europe this shares the history data information from  to  and forecast from  to  this report provides a detailed analysis of the market its dynamics structure characteristics main players growth and demand drivers etc as a detailed analysis report it covers all details inside analysis and opinion in bcg vaccine industry this report focus global and europe market it covers details playe read more global onychomycosis tinea unguium drug detailed analysis report  jul  detailed analysis research  pages    code  mrs   this report splits onychomycosis tinea unguium drug by product drug form by product usage type this shares the history data information from  to  and forecast from  to  and this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in onychomycosis tinea unguium drug industry this report fo read more life science analytics  global market outlook  jun  stratistics mrc  pages    code  mrs   according to stratistics mrc the global life science analytics market is expected to grow from  billion in  to reach  billion by  with a cagr of  some of the factors propelling the market growth are raising demand for analytics in sales and marketing applications increasing need of these solutions especially in clinical trials and improvements in technological advancements however lack of skilled professionals huge implementation costs and financial limitations read more chronic kidney disease ckd drugs  global market outlook  jul  stratistics mrc  pages    code  mrs   according to stratistics mrc the global chronic kidney disease ckd drugs market is expected to grow from  billion in  to reach  billion by  with a cagr of  drivers that are shaping the global market include growing incidences of chronic kidney diseases rise in aged population rising incidence of diabetes and obesity related disorders significant unmet requirements and beneficial reimbursement policies on the other hand factors such as intense competition fr read more acaricides  global market outlook  jul  stratistics mrc  pages    code  mrs   according to stratistics mrc the global acaricides market is expected to grow from  million in  to reach  million by  with a cagr of  high demand for meat dairy products and crops growth in crop protection industry and rise in productivity are some of the factors propelling the market growth however increase in cost alternative acaricides sources and regulatory restrictions are the factors suppressing the market on the other hand expansion of bioactive aca read more global and united states bacillus subtilis depth research report  jul  united states research  pages    code  mrs   this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a depth research report it covers all details inside analysis and opinion in bacillus subtilis industry this report focus united states market it covers details players regions product type and other details as following major companies bayer germany basf germany tonglu huifeng china kernel biotech china w read more global bacterial vaginosis drug market rport  jun  bisreport  pages    code  mrs   global bacterial vaginosis drug market report  full report  multi license section  section price as below page  chart and figure  publisher bisreport delivery time  hour contact salesbisreportcom phone  with the slowdown in world economic growth the bacterial vaginosis drug industry has also suffered a certain impact but still maintained a relatively optimistic growth the past four years bacterial vaginosis drug market size to maintain read more global alzheimers disease drug market rport  jun  bisreport  pages    code  mrs   global alzheimer’s disease drug market report  full report  multi license section  section price as below page  chart and figure  publisher bisreport delivery time  hour contact salesbisreportcom phone  with the slowdown in world economic growth the alzheimer’s disease drug industry has also suffered a certain impact but still maintained a relatively optimistic growth the past four years alzheimer’s disease drug market size to maintain read more global protein powder detailed analysis report  jul  detailed analysis research  pages    code  mrs   this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in protein powder industry this report splits protein powder market price size first speciality second speciality protein powder flavors which covers the history data information from  to  and forecast from  to  this report focus glob read more opioidinduced constipation oic  pipeline review h  jul  global markets direct  pages    code  mrs   opioidinduced constipation oic  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide opioidinduced constipation oic  pipeline review h  provides an overview of the opioidinduced constipation oic toxicology pipeline landscape opioids are effective pain relievers but often have the side effect of constipation these medicines affect the gastrointestinal tract in a variety of ways opioids increase the amo read more payment mode single user  usd multi user  usd corporate user  usd latest report  global nonslip epoxy glass flake paint market research report  global parking sensors market research report  global nitrogen oxide sensor market research report  global nuclear density gauge market research report  global automotive interior materials market research report view more latest news global chitosan market set for rapid growth to reach usd  billion by  zion market research has published a new report titled chitosan market for water treatment biomed development of ecommerce to reshape global mobile hotspot router market mobile hotspot is a popular feature on smart phones that provide wireless internet access on many global carotenoids market is expected to reach around usd  billion in  zion market research has published a new report titled carotenoids market by type astaxanthin be soaring demand from food  beverages industry to act as prime driving for ascorbic acid market reports zion market research ascorbic acid is extensively available in nature mostly rich in leafy vegetables and fresh fruits global energy management system ems market is set for a rapid growth and is expected to reach usd  million by  zion market research has published a new report titled energy management system market ems by so view more single user  usd view pricing find help how to order disclaimer faqs return policy sitemap our company about us terms and conditions privacy policy we accept the following payment methods     market research store  market research reports tcon  stock quote for tracon pharmaceuticals inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices tracon pharmaceuticals inc nasdaq tcon us markets closed adchoices  ▲   after hours     july    pm edt delayed  minutes source nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news tracon pharmaceuticals inc tcon ipo nasdaq  days ago tracon pharmaceuticals inc insiders on board members bloomberg  days ago company overview of tracon pharmaceuticals inc bloomberg  constellation brands inc nysestzb receives an update from brokers desotoedgecom  day ago santen and tracon announce initiation of a phase a study of de for the treatment of wet agerelated macular degeneration  traders  days ago perritt capital management upped innerworkings inwk stake tracon pharmaceuticals tcon shorts down by  the bibey post  days ago proto labs inc nyseprlb stake decreased by american international group inc hoyentvcom  days ago news  eventstcon inside fidelity  in volatile markets do analysts think you should buy tracon pharmaceuticals inc tcon desotoedgecom  tracon pharmaceuticals inc tcon ukinvestingcom  netflix t bio tarena lead nasdaq gainers nflx ttoo tedu qure qdel pbyi educ skis chke aaoi fold fx pips  tracon pharmaceuticals inc nasdaqtcon stock rating lowered by zacks investment research bns  tracon pharmaceuticals nasdaqtcon given daily news sentiment rating of  breeze  stifel nicolaus lowers tracon pharmaceuticals inc tcon price target to  breeze  health pharma bio stocks rise on nasdaq today – ptx aldr chke yndx zfgn gemp asna trvn teso lptx aaoi fx pips  stifel financial corp increases stake in tracon pharmaceuticals inc nasdaqtcon bns  tracon pharmaceuticals inc tcon cainvestingcom  tracon pharmaceuticals inc tcon price target cut to  by analysts at stifel nicolaus themarketsdailycom  adchoices adchoices adchoices markets dow dow ▲    last updated time   pm edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft tracon pharmaceuticals inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports tracon pharmaceuticals inc  product pipeline review   tracon pharmaceuticals inc  product pipeline review   wgr  december  global  pages global markets direct description table of content sample report enquiry before buy related reports tracon pharmaceuticals inc  product pipeline review  summaryglobal markets direct’s ‘tracon pharmaceuticals inc  product pipeline review  ’ provides an overview of the tracon pharmaceuticals inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of tracon pharmaceuticals inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of tracon pharmaceuticals inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of tracon pharmaceuticals inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the tracon pharmaceuticals inc’s pipeline productsreasons to buy evaluate tracon pharmaceuticals inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of tracon pharmaceuticals inc in its therapy areas of focus identify new drug targets and therapeutic classes in the tracon pharmaceuticals inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of tracon pharmaceuticals inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of tracon pharmaceuticals inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of tracon pharmaceuticals inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures tracon pharmaceuticals inc snapshot tracon pharmaceuticals inc overview key information key facts tracon pharmaceuticals inc  research and development overview key therapeutic areas tracon pharmaceuticals inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities tracon pharmaceuticals inc  pipeline products glance tracon pharmaceuticals inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities tracon pharmaceuticals inc  early stage pipeline products preclinical productscombination treatment modalities tracon pharmaceuticals inc  drug profiles trc product description mechanism of action rd progress trc product description mechanism of action rd progress docetaxel  ceramide product description mechanism of action rd progress tracon pharmaceuticals inc  pipeline analysis tracon pharmaceuticals inc  pipeline products by target tracon pharmaceuticals inc  pipeline products by route of administration tracon pharmaceuticals inc  pipeline products by molecule type tracon pharmaceuticals inc  pipeline products by mechanism of action tracon pharmaceuticals inc  recent pipeline updates tracon pharmaceuticals inc  dormant projects tracon pharmaceuticals inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablestracon pharmaceuticals inc key information tracon pharmaceuticals inc key facts tracon pharmaceuticals inc  pipeline by indication  tracon pharmaceuticals inc  pipeline by stage of development  tracon pharmaceuticals inc  monotherapy products in pipeline  tracon pharmaceuticals inc  combination treatment modalities in pipeline  tracon pharmaceuticals inc  phase ii  tracon pharmaceuticals inc  phase i  tracon pharmaceuticals inc  preclinical  tracon pharmaceuticals inc  pipeline by target  tracon pharmaceuticals inc  pipeline by route of administration  tracon pharmaceuticals inc  pipeline by molecule type  tracon pharmaceuticals inc  pipeline products by mechanism of action  tracon pharmaceuticals inc  recent pipeline updates  tracon pharmaceuticals inc  dormant developmental projects list of figurestracon pharmaceuticals inc  pipeline by top  indication  tracon pharmaceuticals inc  pipeline by stage of development  tracon pharmaceuticals inc  monotherapy products in pipeline  tracon pharmaceuticals inc  pipeline by top  target  tracon pharmaceuticals inc  pipeline by top  route of administration  tracon pharmaceuticals inc  pipeline by top  molecule type  tracon pharmaceuticals inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send tracon pharmaceuticals inc  ipo candy skip to primary navigation skip to content becomeamember ipo candyeveryones favorite site for ipo insights and analysismain navigationhome » tracon pharmaceuticals inctracon pharmaceuticals inc  by tracon pharmaceuticals inc a clinical stage biopharmaceutical company focuses on the development and commercialization of novel targeted therapeutics for cancer agerelated macular degeneration and fibrotic diseases its lead product candidate is trc which is in phase ii clinical trials for oncology indications including soft tissue sarcoma renal cell carcinoma glioblastoma and hepatocellular carcinoma the company is also planning for clinical trials of trc including a phase ii clinical trial in patients with breast cancer and hepatocellular carcinoma a phase i clinical trial in patients with colorectal cancer and a phase i clinical trial in patients with lung cancer as well as conducting preclinical studies of trc in amd in addition it has completed various phase i and phase ii clinical trials of trc for the indications such as solid tumors glioblastoma hepatocellular carcinoma and renal cell carcinoma as well as breast prostate bladder and ovarian cancers further the company product candidates comprise trc an antiendoglin antibody that is in preclinical stage for the treatment of fibrotic diseases and trc a small molecule which is in clinical development for the treatment of lung cancer and glioblastoma tracon pharmaceuticals inc has collaboration agreements with national cancer institute and santen the company was formerly known as lexington pharmaceuticals inc and changed its name to tracon pharmaceuticals inc in march  tracon pharmaceuticals inc was founded in  and is headquartered in san diego california tracon pharmaceuticals inc tracon pharmaceuticals inc a clinical stage biopharmaceutical company focuses on the development and commercialization of novel targeted therapeutics for cancer agerelated macular degeneration and fibrotic diseases its lead product candidate is trc which is in phase ii clinical trials for oncology indications including soft tissue sarcoma renal cell carcinoma glioblastoma and hepatocellular carcinoma the company is also planning for clinical trials of trc including a phase ii clinical trial in patients with breast cancer and hepatocellular carcinoma a phase i clinical trial in patients with colorectal cancer and a phase i clinical trial in patients with lung cancer as well as conducting preclinical studies of trc in amd in addition it has completed various phase i and phase ii clinical trials of trc for the indications such as solid tumors glioblastoma hepatocellular carcinoma and renal cell carcinoma as well as breast prostate bladder and ovarian cancers further the company product candidates comprise trc an antiendoglin antibody that is in preclinical stage for the treatment of fibrotic diseases and trc a small molecule which is in clinical development for the treatment of lung cancer and glioblastoma tracon pharmaceuticals inc has collaboration agreements with national cancer institute and santen the company was formerly known as lexington pharmaceuticals inc and changed its name to tracon pharmaceuticals inc in march  tracon pharmaceuticals inc was founded in  and is headquartered in san diego california twitter facebook google linkedin tracon pharmaceuticals incptracon pharmaceuticals inc a clinical stage biopharmaceutical company focuses on the development and commercialization of novel targeted therapeutics for cancer agerelated macular degeneration and fibrotic diseases its lead product candidate is trc which is in phase ii clinical trials for oncology indications including soft tissue sarcoma renal cell carcinoma glioblastoma and hepatocellular carcinoma the company is also planning for clinical trials of trc including a phase ii clinical trial in patients with breast cancer and hepatocellular carcinoma a phase i clinical trial in patients with colorectal cancer and a phase i clinical trial in patients with lung cancer as well as conducting preclinical studies of trc in amd in addition it has completed various phase i and phase ii clinical trials of trc for the indications such as solid tumors glioblastoma hepatocellular carcinoma and renal cell carcinoma as well as breast prostate bladder and ovarian cancers further the company product candidates comprise trc an antiendoglin antibody that is in preclinical stage for the treatment of fibrotic diseases and trc a small molecule which is in clinical development for the treatment of lung cancer and glioblastoma tracon pharmaceuticals inc has collaboration agreements with national cancer institute and santen the company was formerly known as lexington pharmaceuticals inc and changed its name to tracon pharmaceuticals inc in march  tracon pharmaceuticals inc was founded in  and is headquartered in san diego californiap caunited statesphone  tcon developing targeted drug therapies documents roadshow main categoryhealthcare categoriesdrugs contact httpwwwtraconpharmacom  address university center lane suite  san diego california  united states we love ipos the ipo market provides a magical window into the most exciting technologies emerging consumer trends and important business developments  all testing their mettle in the crucible of the public markets we are constantly learning and researching to deliver the best insights available we are independent we have no vested interests driving our work all the investment banks and brokers on a deal are paid to do a sales and marketing job our job is to remain objective and use a factbased approach to evaluate the potential for an ipo we get the best ratings ipo candy has been recognized since  as the single best place to get commentary analysis and assets in the ipo market the most common writein comment we get from users is that they love what we do we share everything we know with three decades of research under our belt we want to share what we have learned and the best practices we have discovered our ipo university contains texts videos and resources to share our process and help everyone develop their skills become an ipocandy member enjoy the benefits of full access to our content including access to ipo roadshow slideshows and transcripts included in our posts members also get additional insights via email receive our monthly candygram and have access to our ipo calendar become a member